313
Participants
Start Date
June 30, 2014
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
lebrikizumab
Given SC on Days 1, 29, and 57
montelukast [Singulair]
10 mg given orally once daily for 12 weeks
placebo
SC injection given on Days 1, 29, and 57
Sofia
Auckland
Sofia
Soweto
Johannesburg
Veliko Tarnovo
Gabrovo
Rousse
Cape Town
Razgrad
Parow
Cape Town
Cape Town
Beckenham
Varna
The Bronx
Rochester
Fairfax
Henrico
High Point
Hendersonville
Greer
Duluth
Columbus
Winter Park
Cooper City
New Port Richey
Kissimmee
Birmingham
Jindřichův Hradec
Strakonice
Louisville
Avon
Jablonec nad Nisou
Greenfield
Minneapolis
Plymouth
River Forest
Oak Lawn
Normal
St Louis
Papillion
Oklahoma City
McKinney
Dallas
Waco
Houston
Humble
Tomball
Boerne
San Antonio
San Antonio
San Antonio
Denver
Colorado Springs
Scottsdale
Flagstaff
Los Angeles
Los Angeles
Upland
Alhambra
Rancho Mirage
Anaheim
Redwood City
Napa
Stockton
Portland
Medford
Moscow
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Saint Petersburg
Timișoara
Ryazan
Cluj-Napoca
Saratov
Oradea
Yekaterinburg
Iași
Waterbury
Ocean City
Rio de Janeiro
Porto Alegre
Florianópolis
Santo André
Santo André
Brampton
Toronto
Karlovy Vary - Stará Role
Tbilisi
Auckland
Bialystok
Krakow
Krakow
Lodz
Lublin
Poznan
Poznan
Tarnów
Wroclaw
Wroclaw
Caguas
San Juan
San Juan
Bucharest
Spišská Nová Ves
Lyttleton
Pretoria Gauteng Province
Manchester
Hoffmann-La Roche
INDUSTRY